McCormick Q3 Results Beat Sales Estimates

McCormick Q3 results beat sales and margins and reaffirmed guidance while raising cost inflation, pushing traders to weigh margins versus higher costs.

October 01, 2026·2 min read
View all news articles
Flat-vector spice mill motif expanding to symbolize McCormick Q3 results balancing margin gains and higher costs.

KEY TAKEAWAYS

  • Reported net sales were $2.02 billion, up 17.4% with 1.9% organic growth.
  • Adjusted diluted EPS was $0.86, beating estimates of roughly $0.76.
  • Company reaffirmed fiscal-2026 outlook while raising expected cost inflation to 6%-7%.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

McCormick & Company (MKC) reported fiscal third-quarter results on Oct. 1, 2026, for the quarter ended Aug. 31, showing stronger sales and margin gains that beat estimates. The company reaffirmed its fiscal-2026 outlook while flagging higher cost inflation and continued reliance on acquisitions.

Sales Beat and Margin Gains

McCormick posted net sales of approximately $2.02 billion, up 17.4% year over year. Currency added about 0.9 percentage point to reported growth, organic sales rose 1.9%, and McCormick de Mexico contributed roughly 14% of the quarter’s sales increase, surpassing the sales estimate of about $1.98 billion.

Adjusted operating income rose to $359 million from $294 million a year earlier, while operating income declined to $217 million from $289 million in the prior-year quarter. GAAP net income fell to $97.6 million, or $0.36 per diluted share, from $225.5 million, or $0.84, primarily due to special charges. Adjusted diluted EPS was $0.86, compared with $0.85 a year earlier and above analyst estimates of roughly $0.76.

GAAP gross-profit margin expanded 190 basis points year over year, and adjusted gross-profit margin grew 180 basis points.

Outlook and Acquisition Impact

In an investor presentation titled “Business Update, Financial Results, and Outlook | 3Q 2026,” McCormick reaffirmed its fiscal-2026 guidance. The company expects reported net-sales growth of 13%–17% and constant-currency net-sales growth of 12%–16%. It anticipates McCormick de Mexico will contribute 11%–13% of sales growth, with organic sales rising 1%–3%. Reported adjusted operating-income growth is forecast at 16%–20%, with constant-currency growth of 15%–19%. Adjusted EPS is projected between $3.05 and $3.13, reflecting 2%–5% reported growth and 1%–4% constant-currency growth. The company expects adjusted gross-profit margin expansion of 100–120 basis points, cost inflation of 6%–7%, an adjusted tax rate near 24%, and brand-marketing spending to rise at a low- to mid-teens percentage rate. Foreign-exchange rates are expected to provide a roughly 1% tailwind to net sales, adjusted operating income, and adjusted EPS.

Management attributed the improvement in adjusted profits to acquisition accretion, productivity initiatives, pricing, and margin expansion. The presentation described the quarter as reflecting a “solid base business performance and ongoing benefit from McCormick de Mexico.” The guidance indicates that most of the company’s projected sales growth depends on acquisitions rather than organic volume increases, highlighting acquisition reliance amid rising cost pressures.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Liquidia Patent Ruling Threatens YUTREPIA U.S. Sales

Liquidia Patent Ruling Threatens YUTREPIA U.S. Sales

Liquidia patent ruling found YUTREPIA infringes UTHR's patent, raising the prospect of an FDA-directed withdrawal and prompting investor scrutiny.

Sanofi Regeneron Alliance Expands Pipeline

Sanofi Regeneron Alliance Expands Pipeline

Sanofi Regeneron alliance adds four long-acting antibodies with $1 billion upfront and equal cost and profit sharing, a framework investors will weigh.

Nike Earnings: Q1 Preview Tests Turnaround

Nike Earnings: Q1 Preview Tests Turnaround

Nike earnings arrive after the U.S. close; analysts expect weaker revenue and EPS, and traders will watch Greater China and margins for flow shifts.

Nvidia Buyback Expansion Signals Capital Shift

Nvidia Buyback Expansion Signals Capital Shift

Nvidia buyback expansion widens repurchase capacity to $235 billion and raises buyback optionality, shifting near-term investor positioning.

Accenture Earnings Top Guidance, Bookings Ease AI Fears

Accenture Earnings Top Guidance, Bookings Ease AI Fears

Accenture earnings topped guidance as record $22.2 billion quarterly bookings signaled demand resilience and eased AI fears, boosting sector sentiment.

10-Year Treasury Yield Hits 24-Year High

10-Year Treasury Yield Hits 24-Year High

10-year Treasury yield hit a 24-year high amid a global bond rout; BEA's revised Q2 GDP and the Oct. 2 jobs report refocused traders on rates.